BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Abiraterone Acetate

An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.

296+ PubMed studies analyzed · 38 RCTs · Evidence Score: 55.1

Research Domains

Abiraterone Acetate has been studied across 14 research domains including 🔬 Oncology, 💪 Strength & Power, ⏳ Longevity & Aging, 🫁 Liver & Detox, 🫘 Kidney. The primary research focus is 🔬 Oncology with 77% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Abiraterone Acetate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Glycocholic
2 shared targets
Arsenic
2 shared targets
Sulfamethazine
2 shared targets
Propanil
3 shared targets
Eplerenone
2 shared targets
Cetomacrogol
2 shared targets
auricularum
2 shared targets
Norethynodrel
3 shared targets
Tomatine
2 shared targets
Desogestrel
3 shared targets
Loading evidence profile...

This evidence profile for Abiraterone Acetate is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.